4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049449
EVP & Chief Financial Officer sold 4,200 shares at an average $14.31 ($60,102)
- EVP & Chief Financial Officer acquired 7,697 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MCGRATH JOHN EVP & Chief Financial Officer | 2017-08-15 | Option exercise | +7,697 | 125,157 | D | ||
| MCGRATH JOHN EVP & Chief Financial Officer | 2017-08-15 | Sale | −2,100 | $14.23 | $29,883 | 123,057 | D |
| MCGRATH JOHN EVP & Chief Financial Officer | 2017-08-16 | Sale | −2,100 | $14.39 | $30,219 | 120,957 | D |
| Derivatives | |||||||
| MCGRATH JOHN EVP & Chief Financial Officer | 2017-08-15 | Option exercise · Restricted Stock Units | −7,697 | 12,829 | I | ||
| Open-market sales · 4,200 sh · avg $14.31 · $60,102 | |||||||
Loading xslF345X03/doc4.xml…